Deoxycholic acid regulatory update

FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee scheduled a meeting on March 9 to review an NDA from Kythera for ATX-101 to reduce submental (under chin) fat. The PDUFA date is May 13. The ...